Maise Al Bakir
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Journal: Nature
Published: January 14, 2026
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction.
Journal: Cell
Published: February 23, 2025
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.
Journal: Nature
Published: July 04, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Journal: Cell
Published: December 13, 2023
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Journal: Nature communications
Published: September 12, 2023
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling.
Journal: Nature cell biology
Published: July 07, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Journal: Nature genetics
Published: June 25, 2023
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Journal: Nature communications
Published: June 06, 2023
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Journal: Cancer discovery
Published: December 20, 2022
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.
Journal: Nature
Published: December 16, 2022
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Journal: Nature
Published: March 07, 2022
Last Updated: 09/26/2026